Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (28) clinical trials

Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease

Previous studies have indicated that Fermented Protaetia brevitarsis seulensis powder may have the ability to improve liver function in adults with alcohol-induced liver disease. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on liver function in adults with alcohol-induced ...

Phase N/A

Phase I-II FIH TROP2 ADC Advanced Unresectable/Metastatic Solid Tumors Refractory to Standard Therapies

This is an open label, Phase I-II, first in human (FIH) study for SKB264 as monotherapy in patients who have locally advanced unresectable or metastatic solid tumor that is refractory to all standard therapies. TROP2 (trophoblast antigen 2) assessments will not be performed prior to enrollment but it will be ...

Phase

VNRX-5024 Safety and PK in Healthy Adult Volunteers

This is a 2-part dose-ranging study to evaluate the safety and pharmacokinetics of escalating doses of VNRX-5024. Subjects will be enrolled in one of three dose cohorts. They will receive a single dose on Day 1 in Part 1 and will proceed into the multiple dose Part 2 of the ...

Phase

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance

AIMS OF STUDY The aim of this study is to investigate whether ingestion of curcumin will prevent hepatic insulin resistance (assessed by homeostatic model assessment of insulin resistance (HOMA-IR)) induced by short-term oral glucocorticoid (prednisolone) administration in overweight and obese participants. BACKGROUND The increasing incidence and prevalence of obesity and ...

Phase N/A

Brain Effect of Vagal Nerve Stimulation at Rest and Pain

Following informed written consent and screening questionnaires to characterize psychophysiological traits including personality and anxiety/depression inventory, each subject will have a nasogastric tube inserted with the attached distensible balloon positioned in the distal oesophagus. Painful oesophageal stimulation will be achieved by inflation of the balloon to a pain threshold pre-determined ...

Phase N/A

AG-120 in People With IDH1 Mutant Chondrosarcoma

This study is being done to see whether AG-120 is an effective and safe treatment for people with advanced/metastatic or recurrent chondrosarcoma that has IDH1 mutation.

Phase

A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies

Patients will be randomized in a 1:1 ratio by the last digit of the patient's identification number, where odd numbers will be assigned to the control group (receiving standard of care follow-up) and even numbers will be assigned to the experimental group. Patients in the experimental arm will receive automatically ...

Phase N/A

A Study of Armed Activated T-Cells in Patients With Advanced Pancreatic Cancer

The purpose of this study is to find the safest dose and identify any bad side effects of EGFR-BATs (bispecific antibody-armed activated T cells) for people with advanced pancreatic cancer who have already received first-line standard chemotherapy.

Phase

Anlotinib Hydrochloride for Soft Tissue Sarcoma Patients.

This regional multi-center study is planned to be carried out in Guangdong and Sichuan provinces. 48 cases are preliminarily expected to be included. The study will start in January 2019 and end in December 2019. It is expected that the trial will end in December 2020. This study evaluating the ...

Phase

GEN2 Directed Cancer Immunotherapy Trial

This clinical trial will be divided into two phases: Phase IA in which the dose, route, and schedule of the GEN2 administration is determined and Phase IB which is designed to explore the activity of GEN2 in patients of a defined or several defined tumor types and stages based on ...

Phase